Description
Inspire Medical Systems, Inc.: Expansion in International Markets & 3 Factors Driving Our ‘Buy’ Rating!
Inspired Medical Systems First Quarter 2024 performance showcases a robust growth trajectory alongside strategic market advancements and impending innovations. The company reported a notable increase in revenue, which reached $164 million, marking a 28% year-over-year growth. This uplift was primarily driven by enhanced penetration in existing markets and expansion into new territories, both domestically and internationally. U.S. revenue climbed to $155.8 million, showing a 25% increase, underpinned by a rising number of implanting centers and sales territories. Notably, international revenue, particularly from Europe, witnessed a significant surge of 141%, totaling $8.2 million—reflective of a strong recovery in Germany following recent regulatory approvals.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!